CIK 0000879169
- Large accelerated filer
INCYTE CORP
Sign in to watch- Ticker
- INCY
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943136539
- Phone
- +1 302-498-6700
- Business address
- 1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
- Former names
- INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
- 4 Grant or award CMO & Head of Late-Stage Dev. acquired 39,049 shares (grant or award)
- 4 Grant or award Director acquired 842 shares (grant or award)
- 4 Grant or award Director acquired 269 shares (grant or award)
- 4 Grant or award Director acquired 265 shares (grant or award)
- 4 Shares withheld for taxes EVP, GM, Dermatology US gave up 537 shares (to pay taxes)
- 4 Planned sale President, R&D sold 18,667 shares at $94.24 ($1,759,178)
- 4 Planned sale President, R&D sold 18,668 shares at $100.91 ($1,883,788)
- 4 Shares withheld for taxes EVP, Head of Tech. Operations gave up 185 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Head of Incyte Intl gave up 111 shares (to pay taxes)
- 4 Grant or award EVP, Head of Incyte Intl acquired 8,911 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes EVP, Head of Tech. Operations gave up 429 shares (to pay taxes)
- 4 Planned sale EVP, Head of US Oncology sold 10,856 shares at $109.07 ($1,184,064)
- 4 Planned sale EVP & Chief Medical Officer sold 15,634 shares at $101.70 ($1,589,978)
- 4 Grant or award Director acquired 241 shares (grant or award)
Page 4 of 82 · 1,626 filings